Human Oncology & Pathogenesis Program

The Michael Berger Lab

Share
Print
Back to Top

Research

Michael Berger, Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Michael F. Berger, PhD
Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

The focus of the Berger laboratory is to characterize the spectrum of genetic mutations in human tumors in order to identify biomarkers of cancer progression and drug response.

View Lab Overview

Researchers in the Berger laboratory

Featured News

Finding
Rack of blood vials
Secondary Leukemia: Research Suggests New Ways to Understand What Causes This Side Effect of Cancer Treatment

Finding
MSK investigators Michael Berger and David Solit.
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

Pictured: Michael Berger, Agnès Viale & David Solit
Landmark $100 Million Gift from the Marie-Josée and Henry R. Kravis Foundation Supports a Groundbreaking Approach to Precision Oncology

View All Featured News

Publications

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, Hyman DM, Solit DB, Robson ME, Baselga J, Arcila ME, Ladanyi M, Tallman MS, Levine RL, Berger MF. Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4. doi: 10.1016/j.stem.2017.07.010. Epub 2017 Aug 10.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, Mukherjee S, Ravichandran V, Cambria R, Galle J, Abida W, Arcila ME, Benayed R, Shah R, Yu K, Bajorin DF, Coleman JA, Leach SD, Lowery MA, Garcia-Aguilar J, Kantoff PW, Sawyers CL, Dickler MN, Saltz L, Motzer RJ, O’Reilly EM, Scher HI, Baselga J, Klimstra DS1, Solit DB, Hyman DM, Berger MF, Ladanyi M, Robson ME, Offit K. JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137.

Clinical and molecular characterization of patients with cancer of unknown primary in the modern era. Varghese AM, Arora A, Capanu M, Camacho N, Won HH, Zehir A, Gao J, Chakravarty D, Schultz N, Klimstra DS, Ladanyi M, Hyman DM, Solit DB, Berger MF, Saltz LB. Ann Oncol. 2017 Dec 1;28(12):3015-3021. doi: 10.1093/annonc/mdx545.

View All Publications

People

Michael Berger, Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

Michael F. Berger, PhD

Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

  • Researcher Michael Berger focuses on massively parallel sequencing of tumor DNA for biomarker discovery and clinical diagnostics.
  • PhD, Harvard University
[email protected]
Email Address
646-888-3386
Office Phone
View physician profile
Physician profile

Members

Kanika Arora

Senior Computational Biologist

Mukta Asnani

Senior Research Assistant, CMO Technology Innovation

Viswatej Avutu

Fellow

David Brown

Senior Computational Biologist, CMO Technology Innovation

Madison Darmofal
Madison Darmofal

WGS Graduate Student

Sebastià Franch Exposito
Sebastià Franch Exposito

Research Fellow

Adrian Fraiha
Adrian Fraiha

Bioinformatics Software Engineer, cfDNA Informatics

Maysun Hasan, Computational Biologist, CMO Technology Innovation
Maysun Hasan

Computational Biologist, CMO Technology Innovation

Ian Johnson, Bioinformatics Engineer
Ian Johnson

Bioinformatics Engineer, CMO Technology Innovation

Brian Houck- Loomis, Manager, CMO Technology Innovation
Brian Loomis

Manager, CMO Technology Innovation

Fanli Meng
Fanli Meng

Research Lab Manager, CMO Technology Innovation

Kamal Menghrajani

Assistant Attending

Charles Murphy

Senior Computational Biologist, cfDNA Informatics

Johnathan Rafailov

Bioinformatics Tech

Ezra Rosen
Ezra Rosen

Assistant Attending

Ronak Shah
Ronak Shah

Principal Computational Biologist, cfDNA Informatics

Shalabh Suman
Shalabh Suman

Senior Computational Biologist

Grittney Tam
Grittney Tam

Senior Research Assistant, CMO Technology Innovation

Giang Vo

Research Assistant, CMO Technology Innovation

Lab Alumni
Angela Rose Brannon, PhD
Angela Rose Brannon

Research Fellow

Gregory McDermott
Gregory McDermott

Medical Student

Sasinya Scott
Sasinya Scott

Research Technician

Nancy Bouvier
Nancy Bouvier

Senior Project Manager

Niedzica Camacho-Ordonez
Niedzica Camacho-Ordonez

Research Fellow

Xiaohong Jing
Xiaohong Jing

Lab Manager, CMO Technology Innovation

Juber Ahamad Patel
Juber Ahamad Patel

Computational Biologist, CMO Technology Innovation

Dilmi Perera, Research Fellow
Dilmi Perera

Research Fellow

Sandeep Raj
Sandeep Raj

Graduate Research Assistant

Jonathan Reichel
Jonathan Reichel

Computational Biologist, CMO Technology Innovation

Maha Shady
Maha Shady

Bioinformatics Tech

Preethi Srinivasan
Preethi Srinivasan

Graduate Student

Jiabin Tang
Jiabin Tang

Group Leader, Innovation Laboratory

Helen Won, MS
Helen Won

Computational Biologist

Wendy Yang
Wendy Yang

Clinical Research Fellow

Peter Zheng
Peter Zheng

Bioinformatics Technician

Lab Affilations

Open Positions

Career Opportunities

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michael F. Berger discloses the following relationships and financial interests:

  • Advances in Genome Biology and Technology (AGBT)
    Provision of Services (uncompensated)
  • American Association for Cancer Research
    Provision of Services (uncompensated)
  • American Society of Clinical Oncology (ASCO)
    Provision of Services
  • Cold Spring Harbor Laboratory
    Provision of Services (uncompensated)
  • Cycle for Survival
    Provision of Services (uncompensated)
  • European Molecular Biology Laboratory
    Provision of Services (uncompensated)
  • European Society for Medical Oncology (ESMO)
    Provision of Services (uncompensated)
  • Fox Chase Cancer Center
    Provision of Services
  • Hospital Sirio-Libanes
    Provision of Services
  • JCO Precision Oncology
    Provision of Services (uncompensated)
  • Journal of Molecular Diagnostics
    Provision of Services (uncompensated)
  • Journal of Visualized Experiments
    Provision of Services (uncompensated)
  • Qiagen
    Provision of Services (uncompensated)
  • Stand Up to Cancer
    Provision of Services (uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: